Piperacillin-Tazobactam (TZP) Resistance in Escherichia coli Due to Hyperproduction of TEM-1 β-Lactamase Mediated by the Promoter Pa/Pb

Overview of attention for article published in Frontiers in Microbiology, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 29 publications that cite this research output.

29

The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.

A high-resolution genomic and phenotypic analysis of resistance evolution of an Escherichia coli strain from a critical care patient treated with piperacillin/tazobactam

Preprint in medRxiv (January 2024)

Semi-mechanistic modeling of resistance development to β-lactam and β-lactamase-inhibitor combinations

Article in Journal of Pharmacokinetics and Pharmacodynamics (November 2023)

Genetic determinants underlying the progressive phenotype of β-lactam/β-lactamase inhibitor resistance in Escherichia coli

Article in Microbiology Spectrum (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.